January 2024

The five widest Discovery Gaps at the end of January 2024, revisited today from the same public filings. Descriptive, not predictive.

NEXT—NextDecade Corp

All industries

Then · 31 Jan 2024: Discovery Gap Very high (100/100)·AIR Weak (40/100)
Now · 7 Oct 2026: Discovery Gap Very high (90/100)·AIR Weak (35/100)·Left the top 5

Since then: Management change (29 Sep 2026)·Commercial traction (2 Jul 2026)·Catalyst (2 Jul 2026)·Catalyst (17 Jun 2026)·Commercial traction (17 Jun 2026)·Management change (3 Jun 2026)

IE—Ivanhoe Electric Inc.

All industries

Then · 31 Jan 2024: Discovery Gap Very high (97/100)·AIR Weak (40/100)
Now · 7 Oct 2026: Discovery Gap Very high (78/100)·AIR Weak (33/100)·Left the top 5

Since then: Catalyst (23 Sep 2026)·Management change (3 Aug 2026)·Commercial traction (7 Jul 2026)·Commercial traction (28 May 2026)·Management change (20 May 2026)·Catalyst (11 May 2026)

RXRX—RECURSION PHARMACEUTICALS, INC.

Biotech

Then · 31 Jan 2024: Discovery Gap Very high (94/100)·AIR Neutral (54/100)
Now · 7 Oct 2026: Discovery Gap Medium (17/100)·AIR Neutral (55/100)·Left the top 5

Since then: Commercial traction (15 Sep 2026)·Catalyst (5 Aug 2026)·Catalyst (6 May 2026)·Management change (28 Apr 2026)·Management change (25 Mar 2026)·Catalyst (25 Feb 2026)

PHAT—Phathom Pharmaceuticals, Inc.

Biotech

Then · 31 Jan 2024: Discovery Gap Very high (94/100)·AIR Cautious (45/100)
Now · 7 Oct 2026: Discovery Gap Medium (20/100)·AIR Cautious (43/100)·Left the top 5

Since then: Catalyst (29 Sep 2026)·Catalyst (30 Jul 2026)·Catalyst (23 Jun 2026)·Catalyst (30 Apr 2026)·Catalyst (26 Feb 2026)·Catalyst (7 Jan 2026)

TLRY—Tilray Brands, Inc.

Biotech

Then · 31 Jan 2024: Discovery Gap Very high (94/100)·AIR Cautious (45/100)
Now · 7 Oct 2026: Discovery Gap Low (0/100)·AIR Neutral (54/100)·Left the top 5

Since then: Catalyst (8 Sep 2026)·Catalyst (4 Aug 2026)·Catalyst (28 Jul 2026)·Catalyst (24 Jun 2026)·Catalyst (3 Jun 2026)·Catalyst (21 Apr 2026)